Enoxaparin sodium
- Generic Name
- Enoxaparin sodium
- Brand Names
- Lovenox, Inhixa
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9005-49-6
- Unique Ingredient Identifier
- E47C0NF7LV
- Background
Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies. Enoxaparin markedly reduces the incidence of venous thromboembolism in hosp...
- Indication
Enoxaparin is indicated for the prevention of ischemic complications in unstable angina and in non Q-wave myocardial infarction; it is indicated in conjunction with percutaneous intervention and/or other treatment for the management of acute ST elevation myocardial infarction.
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Acute Myocardial Infarction With ST Segment Elevation, Deep Vein Thrombosis, Ischemic complications caused by non-q wave myocardial infarction, Ischemic complications caused by unstable angina
- Associated Therapies
- Percutaneous Coronary Intervention (PCI)
Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
- Conditions
- Interventions
- First Posted Date
- 2011-05-20
- Last Posted Date
- 2015-06-18
- Lead Sponsor
- Eurofarma Laboratorios S.A.
- Target Recruit Count
- 62
- Registration Number
- NCT01356992
Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
- Conditions
- Interventions
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Les Laboratoires des Médicaments Stériles
- Target Recruit Count
- 153
- Registration Number
- NCT01354704
- Locations
- 🇹🇳
Hospital Charle Nicolle, Tunis, Tunis BAB SOUIKA, Tunisia
Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients
- Conditions
- Interventions
- First Posted Date
- 2011-03-30
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Lisa Louwers
- Registration Number
- NCT01325779
- Locations
- 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States
Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
- Conditions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2010-12-06
- Lead Sponsor
- Monash Medical Centre
- Target Recruit Count
- 330
- Registration Number
- NCT01252420
- Locations
- 🇦🇺
Monash Medical Centre, Southern Health, Melbourne, Victoria, Australia
🇦🇺Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Royal Adelaide Hospital, Adelaide, South Australia, Australia
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1973
- Registration Number
- NCT01225822
- Locations
- 🇦🇹
1160.19.43001 A.ö. Krankenhaus d. Statutarstadt Wiener Neustadt, Wr. Neustadt, Austria
🇨🇿1160.19.42006 Hospital Mlada Boleslav, Mlada Boleslav, Czech Republic
🇧🇪1160.19.32005 Virga Jesseziekenhuis, Gent, Belgium
Dose-confirmatory Bridging Study in Total Knee Replacement
- Conditions
- Interventions
- First Posted Date
- 2010-09-22
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 302
- Registration Number
- NCT01206972
Dose-confirmatory Bridging Study in Total Hip Replacement
- Conditions
- Interventions
- First Posted Date
- 2010-09-21
- Last Posted Date
- 2017-01-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 402
- Registration Number
- NCT01205932
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Daiichi Sankyo Co., Ltd.
- Target Recruit Count
- 610
- Registration Number
- NCT01181167
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Daiichi Sankyo Co., Ltd.
- Target Recruit Count
- 716
- Registration Number
- NCT01181102
Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
- Conditions
- Interventions
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- University of Magdeburg
- Target Recruit Count
- 22
- Registration Number
- NCT01149304
- Locations
- 🇩🇪
Clinic for Radiology and Nuclear Medicine, Magdeburg, Sachsen-Anhalt, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.